ARTICLES LIST

 

Total Results: 16203

Media ID Source Name Media Type Language Media Name Media Description Keywords Keywords Link to Article
1362 National Cancer Institute Html en Hot Flashes and Night Sweats (PDQ®)–Health Professional Version Expert-reviewed information summary about causes and treatment of hot flashes and night sweats in cancer patients.
hot flash scores0.45918
tamoxifen-induced hot flashes0.487401
Loprinzi CL0.545839
menopausal symptoms0.464059
Barton DL0.475444
nocturnal hot flashes0.494473
black cohosh0.488248
androgen deprivation therapy0.448869
clinical trial0.448391
breast cancer treatment0.460098
breast cancer patients0.474226
postmenopausal breast cancer0.456276
hot flashes merits0.487946
Natl Cancer Inst0.459556
breast cancer survivors0.509665
North Central Cancer0.472407
hot flash reduction0.458714
hot flashes0.905213
hormone replacement therapy0.476539
et al.0.506432
women0.50642
core body temperature0.45737
night sweats0.457026
study0.456946
stage breast cancer0.454333
hot flash studies0.449594
hot flushes0.465978
breast cancer diagnosis0.451556
postmenopausal hot flashes0.500892
breast cancer recurrence0.47207
hot flash management.0.448239
PUBMED Abstract0.549613
Cancer Res Treat0.462211
nighttime hot flashes0.501942
hot flash frequency0.50736
menopausal hot flashes0.487616
Cancer Treatment Group0.476248
hot flash management0.49365
postmenopausal women0.477394
breast cancer risk0.486953
Clin Oncol0.505954
receptor–positive breast cancer0.451466
breast cancer0.743246
randomized controlled trial0.545918
hot flash0.591793
healthy postmenopausal women0.454945
prostate cancer0.455636
placebo-controlled trial0.450402
Central Cancer Treatment0.476295
CLICK HERE
1452 National Cancer Institute Html en Cigarette Smoking: Health Risks and How to Quit (PDQ®)–Health Professional Version Expert-reviewed information summary about research and guidelines focused on the prevention and cessation of cigarette smoking.
smoking cessation strategy0.633721
smoking cessation rates0.605741
quit attempt0.552085
effective smoking cessation0.580922
gradual cessation group0.483049
abrupt cessation0.562882
prolonged validated smoking0.480554
lung cancer0.658405
tobacco cessation0.463262
smoking cessation pharmacotherapies0.597527
abrupt smoking cessation0.601297
pipe tobacco smoking0.505275
current smoking0.475722
gradual cessation arm0.465437
nicotine replacement therapy0.54532
randomized trial0.492165
Smoking cessation counseling0.609156
receptor partial agonist0.460896
area-level smoking prevalence0.513667
smoking reduction0.49426
smoking behavior0.469981
smoking cessation treatment0.588411
smoking prevalence data0.513642
tobacco products0.485537
abrupt cessation arm0.472163
smoking cessation0.926558
vs abrupt cessation0.475821
adult cigarette smoking0.474818
gradual cessation method0.466403
cigarette smoking cessation0.573293
cigarette smoking0.62168
smoking cessation pharmacotherapy0.595082
varenicline0.542592
tobacco smoking0.505702
smoking cessation rate.0.602815
gradual cessation0.501212
abrupt cessation group0.489713
nicotinic acetylcholine receptor0.464069
self-reported smoking abstinence0.502629
smoking abstinence0.574891
cigarette smoking prevalence0.566333
randomized controlled trial0.482431
6-month cessation rates0.474432
nicotine patch0.531368
smoking cessation intervention0.590903
usual smoking patterns0.480697
lung cancer mortality0.510576
varenicline group0.534998
CLICK HERE
1610 National Cancer Institute Html en Myelodysplastic/ Myeloproliferative Neoplasms Treatment (PDQ®)–Health Professional Version Myelodysplastic/myeloproliferative neoplasms (MDS/MPN) are composed of three major myeloid disorders: chronic myelomonocytic leukemia (CMML), juvenile myelomonocytic leukemia (JMML), and atypical chronic myeloid leukemia (aCML). Learn about the clinical features and treatment of these leukemias.
JMML0.47142
5-year estimated probability0.444988
evidence0.458611
host disease grade0.440441
anemia supervenes0.445725
various chemotherapy regimens0.572089
platelet-derived growth factor0.511436
Leukemia Group0.448642
white blood cells0.44993
Myelodysplastic/ Myeloproliferative Neoplasms0.440718
CMML0.717566
marrow stem cell0.463204
myelomonocytic leukemia0.462437
HLA-matched unrelated individuals0.444789
toxic effects0.442066
bone marrow aplasia0.560704
chronic myelomonocytic leukemia0.449424
transplant-related mortality0.457149
World Health Organization0.564993
erythropoietic growth factors0.554859
median age0.543021
level0.460994
randomized trial0.458448
patients0.901262
monthly maintenance0.44579
randomized clinical trial0.484352
major defining feature0.454521
complete remission0.448646
proliferative features0.448887
DNA methyltransferase0.449167
et al.0.534469
young MDS patients0.511634
follow-up study0.441281
Complete hematologic remissions0.570636
JMML leukemia cells0.462656
pyrimidine-analog antimetabolite0.44631
stem cell0.531211
single-agent therapy0.444312
13-cis retinoic acid0.524469
transfusion requirements0.448178
Median actuarial survival0.504944
median duration0.676959
nucleoside azacitidine0.478539
particularly poor prognosis.0.444869
patient survival data.0.445943
bone marrow0.729115
total-body radiation therapy0.553338
allogeneic stem cell0.441128
Juvenile myelomonocytic leukemia0.458499
CLICK HERE
1773 National Cancer Institute Html es Trastornos del sueño (PDQ®)–Versión para profesionales de salud Resumen de información revisada por expertos acerca de las causas de los trastornos del sueño de las personas con cáncer y su manejo.
American Academy0.62007
sleep disturbance0.546203
Sateia MJ0.426893
Sleep Disturbance Scale0.434259
CdV Mejoras0.428861
mg riesgo0.50361
National Sleep Foundation0.473914
Sleep Quality Index0.466452
Simard S0.452533
neglected problem0.428741
sueño mor0.943385
risk factors0.426951
sleep-wake disturbances0.458084
Sleep Disorders0.45951
Oncol Nurs0.45478
PDQ Delirium0.436712
coordinación motriz0.436956
sueño diario0.570793
sleep disruption0.458489
Insomnia Severity Index0.446987
patients with0.455594
Hirshkowitz M0.42487
Pittsburgh Sleep Quality0.464939
Insomnia Severity0.454434
sueño frente0.501612
Roscoe JA0.426353
Oncol Nurs Forum0.453234
Morin CM0.426813
sueño categoría0.493243
Care Cancer0.439262
Palesh OG0.427427
ECA Control0.495325
Savard J0.54747
Sleep Medicine review0.435342
Mustian KM0.426387
patients based0.427546
Rochester Cancer Center-Community0.462263
Clinical Oncology Program0.450218
sleep regulation0.427006
sueño nmor0.697198
Clin Oncol0.506515
Clin North Am0.455007
estadio i–iii0.467766
Center-Community Clinical Oncology0.451231
psychological associations0.42745
Cancer Center-Community Clinical0.464249
Sleep Medicine0.709305
Med Clin North0.456379
Sleep Disorders Classification0.439634
CLICK HERE
1927 National Cancer Institute Html es Tratamiento del linfoma de Hodgkin infantil (PDQ®)–Versión para pacientes Resumen de información revisada por expertos acerca del tratamiento del linfoma de Hodgkin infantil.
siguientes procedimientos0.539535
células madre0.949818
estadio iv0.500925
adultos jóvenes0.452563
órgano cercano.ampliar linfoma0.561365
siguientes elementos0.448931
sudores nocturnos0.484622
faja ajustadora0.430459
siguientes especialistas0.43177
siguientes tipos0.443725
vía oral0.419326
rayos x0.473568
Hodgkin Lymphoma0.582459
abdomen).ampliar linfoma0.535694
detecte.ampliar exploración0.434601
enlace drugs approved0.498183
escáner tep0.492453
niño ayuda0.424524
estadio iiies0.760474
riesgo intermedio0.462626
efectos tardíos0.664689
estadio ie0.575058
células anormales.ampliar aspiración0.485872
PDQ Efectos tardíos0.461638
National Cancer Institute0.420283
sustancia quizás0.427861
siguientes lugares0.433237
siguientes riesgos0.418851
Instituto Nacional0.434896
PDQ Tratamiento0.682769
estadio iie0.500587
Hodgkin recién0.557678
explorador tep0.443167
estadio e0.45134
nuevos tipos0.421275
Physician Data Query0.471298
posibles efectos0.420063
infancia quizás0.428464
estadio iiis0.959473
ósea fabrica glóbulos0.493208
pelvis.ampliar imágenes0.420331
distinta intensidad0.419212
almacena células0.485736
siguientes pruebas0.485604
siguientes estadios0.440037
CLICK HERE
2114 National Cancer Institute Html es Exámenes de detección del cáncer de hígado (hepatocelular) (PDQ®)–Versión para pacientes Sumario de información revisada por expertos sobre pruebas que se usan para detectar el cáncer de hígado (hepatocelular).
hepatitis c0.799278
PDQ Exámenes0.723065
estudio marcadores0.652784
siguientes efectos0.659695
Physician Data Query0.826748
Estados Unidos0.932003
rayos x0.659043
prevención revisa0.639071
sustancias dañinas0.671115
cuerpo usa0.666699
ondas sonoras0.6623
siguientes exámenes0.740755
información ayuda0.645281
National Cancer Institute0.657644
siguientes riesgos0.650336
siguientes sumarios0.743208
Instituto Nacional0.706872
múltiples funciones0.667669
CLICK HERE
3446 National Cancer Institute Html es Consumo de cigarrillo: riesgos para la salud y cómo dejar de fumar (PDQ®)–Versión para profesionales de salud Sumario de información revisada por expertos sobre la investigación y pautas que se enfocan en la prevención y el abandono del tabaquismo.
efectos secundarios comentarios0.501986
leucemia mieloide0.427415
metabolitos carcinógenos0.42791
bupropión marca dosis0.454219
grupo vareniclina0.463468
importancia clínica0.450606
MVL Nicorette DS0.439222
pruebas directas0.619014
MVL Nicoderm CQ0.440426
MVL Commit0.42718
Sin embargo0.467903
muertes prematuras0.469229
largo plazo0.764238
cessation interventions among0.449671
Lung Health Study0.44169
Lancaster T0.545862
defunciones prematuras0.434559
bupropión mejora0.45245
Stead LF0.482703
orientación mejora0.429664
bupropión ap0.446903
Nicotine replacement therapy0.444158
semanas insomnio0.443481
vareniclina mejora0.477582
Estados Unidos0.989049
polacrilex marca dosis0.434801
insomnio riesgo0.427937
smoking cessation0.872626
salud pública0.590985
Database Syst Rev0.689429
abandono gradual versus0.477395
nicotina marca dosis0.473496
beneficio hipotético implícito0.443214
Treating Tobacco Use0.44172
versus trn0.451335
MVL Nicorette0.462807
mejores tasas0.435725
Community Intervention Trial0.530278
Marca Dosis Efectos0.591077
alta calidad0.516955
efectos secundarios advertencias0.436485
compuestos carcinógenos0.426773
tasas promedio0.433836
aductos carcinógenos0.42846
planta cytisus laburnum0.434664
antidepresivo bupropión0.449342
cuello uterino0.576293
MVL Nicotrol0.425887
Surveillance Modeling Network0.440037
CLICK HERE
3523 National Cancer Institute Html es Estudio NCI-MATCH (Análisis Molecular para Selección de Tratamientos) Información sobre el estudio del NCI: Análisis Molecular para Selección de Tratamientos (NCI-MATCH), en el cual los investigadores examinarán tejidos de tumor de pacientes con tumores sólidos y linfomas avanzados que han dejado de responder al tratamiento.
Tumor Profiling0.554625
estudio match0.941659
Investigación Oncológica0.6022
MD Anderson0.61416
Memorial Sloan-Kettering Cancer0.578519
Clinical Trials0.539697
posibles participantes0.607033
C2 MET0.546519
Life Sciences0.627896
laboratorios foundation medicine0.56991
Foundation Medicine0.623082
Memorial Sloan-Kettering identificarán0.577406
estudio comet0.807536
Grupo Cambio0.537516
met amp crizotinib0.576245
como los costos0.539059
seguro médico0.533808
Cancer Center0.605302
MD Anderson Cancer0.572606
tratamiento inscribirán0.618222
sk crizotinib0.541473
cabo estudios0.534561
Caris Life Sciences0.579205
Investigación Oncológica ECOG-ACRIN0.571301
Memorial Sloan-Kettering0.625566
egfr mut afatinib0.573282
NRG Oncology Group0.568484
Iniciativa de Medicina0.538366
Life Sciences identificarán0.57351
CLICK HERE
3573 National Cancer Institute Html en Immunotherapy: Using the Immune System to Treat Cancer Immunotherapies are treatments that restore or enhance the immune system’s natural ability to fight cancer. In just the past few years, the rapidly advancing field of cancer immunology has produced several new methods of treating cancer that increase the strength of immune responses against tumors.
abnormal cells0.352853
CAR T cells0.324531
cancer cells0.817652
immune system activity0.227645
immune responses0.409806
toxic substance0.204832
dendritic cells0.272111
immune system molecules0.223265
white blood cells0.307219
activated T cells0.296761
immune system—research0.253725
immune response0.250155
advanced lung cancer0.212796
cancer treatment vaccine0.201283
clinical trials0.278634
tumor cells0.49599
CD20-expressing cells0.269956
normal cells0.295119
human clinical trials0.248944
antibody-dependent cell-mediated cytotoxicity0.250246
patients0.23385
advanced melanoma0.22903
immune cells0.680701
immune checkpoint inhibitors0.313495
FDA-approved checkpoint inhibitors0.216978
therapeutic antibodies0.216622
cancer cell death0.250231
immunotherapy uses proteins0.212508
CAR T-cell therapy0.397055
natural killer cells0.304861
lymphoma cells0.266327
cells0.903811
different checkpoint protein0.207351
modified T cells0.282987
immune checkpoint proteins0.3798
existing T cells0.321978
certain immune cells0.38886
CLICK HERE
15802 National Cancer Institute Html null About the Blue Ribbon Panel Information about the Cancer Moonshot Blue Ribbon Panel of experts. The panel was established to ensure the Cancer Moonshot's goals and approaches are grounded in the best science.
CLICK HERE

 

 

 

Terms of Use | Privacy Policy
©2017 ARCHES Technology. All Rights Reserved.